Kun Chen

Kun Chen

Auto-generated profile, based on publicly available information

Kun Chen

Department of Clinical Laboratory, Peking University Cancer Hospital & Institute Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Beijing China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
KCKun Chen
Kun Chen
WSWenjia Sun
Wenjia Sun
YJYun Jiang
Yun Jiang
DLDeping Liu
Deping Liu
YZYanyang Zhao
Yanyang Zhao
RQRuomei Qi
Ruomei Qi
Aim. Ginkgolide B is a Ginkgo biloba leaf extract that has been identified as a natural platelet‐activating factor receptor (PAFR) antagonist. We investigated the effect of ginkgolide B on high glucose‐induced TLR4 activation in human umbilical vein endothelial cells (HUVECs). Methods. Protein expression was analyzed by immunoblotting. Small‐interfering RNA (siRNA) was used to knock down PAFR and TLR4 expression. Results. Ginkgolide B suppressed the expression of TLR4 and MyD88 that was induced by high glucose. Ginkgolide B also reduced the levels of platelet endothelial cell adhesion molecule‐1, interleukin‐6, and monocyte chemotactic protein 1. Further, we examined the association between PAFR and TLR4 by coimmunoprecipitation. The result showed that high glucose treatment caused the binding of PAFR and TLR4, whereas ginkgolide B abolished this binding. The functional analysis indicated that PAFR siRNA treatment reduced TLR4 expression, and TLR4 siRNA treatment decreased PAFR expression in high glucose‐treated HUVECs, further supporting the coimmunoprecipitation data. Ginkgolide B inhibited the phosphorylation of Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) and p38 mitogen‐activated protein kinase (MAPK). Conclusion. Ginkgolide B exerted protective effects by inhibiting the TLR4‐mediated inflammatory response in high glucose‐treated endothelial cells. The mechanism of action of ginkgolide B might be associated with inhibition of the JAK2/STAT3 and p38 MAPK phosphorylation.

10 May 2022 in Journal of Immunotherapy
Verified
Journal Article
Closed access
SZShuguang Zhang
Shuguang Zhang
KCKun Chen
Kun Chen
ZZZhenguo Zhao
Zhenguo Zhao
XZXinxin Zhang
Xinxin Zhang
LXLibin Xu
Libin Xu
SYShengji Yu
Shengji Yu
Guanylate binding protein 2 (GBP2) could bind to guanine nucleotides (GMP, GDP, and GTP) and exhibits antiviral activity against influenza virus through the innate immune response. Some researchers have demonstrated that the value of GBP2 in predicting the prognosis of multiple cancers and the complex correlation with immune response. However, the correlation of GBP2 to prognosis and immune cell infiltration level were unknown in skin cutaneous melanoma (SKCM). The GBP2 expression in multiple cancers were evaluated through Tumor Immune Estimation Resource (TIMER) and Oncomine. We also evaluated the influence of GBP2 on overall survival in multiple caners through GEPIA, TIMER, and tissue microarray. The correlation between GBP2 expression level and immune cell or gene markers of immune infiltration level was explored on TIMER and GEPIA. Gene set enrichment analysis was performed using the TCGA dataset. The GBP2 expression level represented a significant reduction and the GBP2 expression was lower compared with the SKCM-Metastasis with P<0.01. Lower GBP2 expression was significantly correlated with the poor overall survival of SKCM patients. Simultaneously, higher GBP2 expression predicted the better SKCM-free survival with P=0.019. GBP2 expression was positively correlated with the infiltration cells of B-cell, CD8+ T-cell, CD4+ T-cell, macrophage, neutrophil, and dendritic cell in SKCM. And there was a significant negative correlation between the expression of GBP2 and DNA methylation in the cBioPortal database (P=3.39e−42). Gene set enrichment analysis revealed that GBP2 was closely correlated with multiple pathways of immune response in cancer. In conclusion, Lower expression of GBP2 associated with less immune cell infiltration and poor prognosis in SKCM and the high promoter methylation of GBP2 represented a promising biomarker for poor prognostication in SKCM.

21 November 2014 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
SXShe-Ling Xie
She-Ling Xie
MYMeng-Hang Yang
Meng-Hang Yang
KCKun Chen
Kun Chen
HHHai Huang
Hai Huang
XZXue-Wei Zhao
Xue-Wei Zhao
BLBing Li
Bing Li

28 August 2023 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
KCKun Chen
Kun Chen
YWYufei Wang
Yufei Wang